Independent register of U.S. FDA drug recalls · updated Nov 2, 2026
RxRecalls Get alerts
Class III · Low risk Ongoing Initiated Sep 25, 2026 (38 days ago)

Tretinoin Cream UPS

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Tretinoin Cream UPS, 0.05%, 20g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals USA Inc., Hawthorne, NY 10532, NDC 51672-1394-0.

Affected NDC 51672-1394-00

Compare with the code on your package — it is the most precise check available.

Drug: Tretinoin

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Tretinoin
NDC 51672-1394
.5 mg/g Cream
Topical
Sun Pharmaceutical Industries, Inc. Rx
Recalling firm
Sun Pharmaceutical Industries INC
NDC code
51672-1394-0
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0035-2027 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm.

Other Tretinoin recalls

See all
Class II · Moderate risk

Tretinoin Capsules

Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.

Terminated Dissolution failure Teva Pharmaceuticals USA Inc NDC 0555-0808-02 D-1156-2022
Class II · Moderate risk

Tretinoin Capsules

Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.

Terminated Dissolution failure Teva Pharmaceuticals USA NDC 0555-0808-02 D-0520-2022
Class II · Moderate risk

Formula 82M

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1424-2020

Other recalls by Sun Pharmaceutical Industries INC

All 2026 recalls
Class II · Moderate risk

Carbamazepine Tablets

CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing

Ongoing cGMP deviation Sun Pharmaceutical Industries INC NDC 51672-4005-3 D-0770-2026